Your session is about to expire
← Back to Search
Genetic Testing
Cancer Treatment for Cancer
N/A
Waitlist Available
Research Sponsored by New Mexico Cancer Care Alliance
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Any patient with a malignant diagnosis at the time of diagnosis or relapse
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Study Summary
This trial will test a new system for genomically tailoring cancer care at the University of New Mexico Cancer Center. The system will use special tests based on patients' genetic makeup to better guide cancer care decisions.
Who is the study for?
This trial is open to anyone diagnosed with cancer at any stage or age, including pregnant women and those with non-cancer genetic disorders. Participants must be able to understand and sign consent forms; however, cognitively impaired adults, those unable to consent for themselves, prisoners, and subjects without enough cancer tissue samples are excluded.Check my eligibility
What is being tested?
The study aims to develop a local system that uses genome sequencing of patients' tumor tissues compared to normal tissues. This personalized medicine approach seeks to identify genetic changes guiding more effective treatment options based on individual genetic profiles.See study design
What are the potential side effects?
Since this trial involves genomic testing rather than drug interventions, traditional side effects are not applicable. However, there may be psychological impacts from learning about one's genetic predispositions towards various conditions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with cancer or my cancer has returned.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of patients with clinically actionable findings
Secondary outcome measures
Frequency of findings (CAF) in cancer patients treated locally
Number of barriers limiting use of genomics information in local patient care
Percentage of patients with secondary findings (SF)
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Cancer Treatment OptionsExperimental Treatment1 Intervention
Blood samples and, for some patients, buccal (mouth cell) samples will be collected at diagnosis and/or relapse. Solid tumor samples will be collected in the normal course of treatment, from biopsy, blood or other specimens. For blood-based cancers such as leukemia, blood and bone marrow specimens will be collected before treatment begins, on day 29 and possibly at a later time point if relapse occurs.
Find a Location
Who is running the clinical trial?
New Mexico Cancer Care AllianceLead Sponsor
70 Previous Clinical Trials
52,217 Total Patients Enrolled
Stuart S Winter, MDStudy ChairUniversity of New Mexico Cancer Center
1 Previous Clinical Trials
6 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am able to give my own consent to participate.I have been diagnosed with cancer or my cancer has returned.I have received treatments before for my condition.I have a genetic disorder that is not cancer-related.I do not have enough cancer tissue samples for study purposes.I am of any age.I (or my guardian) can understand and am willing to sign the consent form.I am either male or female.
Research Study Groups:
This trial has the following groups:- Group 1: Cancer Treatment Options
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an opportunity to join this clinical experiment currently?
"According to the information made available on clinicaltrials.gov, this particular trial is not in need of participants at present. The posting was first submitted on January 1st 2015 and updated most recently on October 4th 2022. Nevertheless, there are 485 other medical trials actively enrolling patients as we speak."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger